Alzheimer disease: Autosomal dominant forms;Génétique de la maladie d'Alzheimer : Formes autosomiques dominantes

Revue Neurologique

Volumn 165, Issue 3, 2009, Pages 223-231

  Guyant Marechal L ^a   Campion, D ^b   Hannequin, D ^a,b  

^a ROUEN UNIVERSITY HOSPITAL   (France)

^b INSERM   (France)

Author keywords

Alzheimer disease; Cerebral amyloid angiopathy; PSEN 1 and PSEN2, APP

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E4; PRESENILIN 1; PRESENILIN 2; PSEN1 PROTEIN, HUMAN; PSEN2 PROTEIN, HUMAN;

ALZHEIMER DISEASE; AUTOSOMAL DOMINANT INHERITANCE; BRAIN HEMORRHAGE; CEREBELLAR ATAXIA; CLINICAL FEATURE; DIFFUSE LEWY BODY DISEASE; EXTRAPYRAMIDAL SYNDROME; GENE MUTATION; HUMAN; ONSET AGE; PHENOTYPE; REVIEW; SPASTIC PARAPLEGIA; VASCULAR AMYLOIDOSIS; AGED; ARTICLE; CHROMOSOME DISORDER; DOMINANT GENE; GENETICS; METABOLISM; MIDDLE AGED; MUTATION; PATHOPHYSIOLOGY; PHYSIOLOGY;

AGE OF ONSET; AGED; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; CHROMOSOME DISORDERS; GENES, DOMINANT; HUMANS; MIDDLE AGED; MUTATION; PHENOTYPE; PRESENILIN-1; PRESENILIN-2;

EID: 65449149436     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurol.2008.10.019     Document Type: Review

References (101)

1. M. Anheim, D. Hannequin, C. Boulay, C. Martin, D. Campion, and C. Tranchant Ataxic variant of Alzheimer's disease caused by Pro117Ala PSEN1 mutation J Neurol Neurosurg Psychiatry 78 2007 1414 1415
2. A. Assini, L. Terreni, R. Borghi, L. Giliberto, A. Piccini, and D. Loqui Pure spastic paraparesis associated with a novel presenilin 1 R278K mutation Neurology 60 2003 150
3. S. Ataka, T. Tomiyama, H. Takuma, T. Yamashita, H. Shimada, and T. Tsutada A novel presenilin-1 mutation (Leu85Pro) in early-onset Alzheimer disease with spastic paraparesis Arch Neurol 61 2004 1773 1776
4. L. Baki, J. Shioi, P. Wen, Z. Shao, A. Schwarzman, and M. Gama-Sosa PS1 activates PI3K thus inhibiting GSK-3 activity and tau overphosphorylation: effects of FAD mutations EMBO J 23 2004 2586 2596
5. R. Baumeister, U. Leimer, I. Zweckbronner, C. Jakubek, J. Grunberg, and C. Haass Human presenilin-1, but not familial Alzheimer's disease (FAD) mutants, facilitate Caenorhabditis elegans Notch signalling independently of proteolytic processing Genes Funct 1 1997 149 159
6. M. Bentahir, O. Nyabi, J. Verhamme, A. Tolia, K. Horre, and J. Wiltfang Presenilin clinical mutations can affect gamma-secretase activity by different mechanisms J Neurochem 96 2006 732 742
7. B.F. Boeve, M. Baker, D.W. Dickson, J.E. Parisi, C. Giannini, and K.A. Josephs Frontotemporal dementia and parkinsonism associated with the IVS1>A mutation in progranulin: a clinicopathologic study Brain 129 2006 3103 3114
8. D.R. Borchelt, G. Thinakaran, C.B. Eckman, M.K. Lee, F. Davenport, and T. Ratovitsky Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo Neuron 17 1996 1005 1013
9. W.S. Brooks, J.B. Kwok, J.J. Kril, G.A. Broe, P.C. Blumbergs, and A.E. Tannenberg Alzheimer's disease with spastic paraparesis and 'cotton wool' plaques: two pedigrees with PS-1 exon 9 deletions Brain 126 2003 783 791
10. L. Cabrejo, L. Guyant-Marechal, A. Laquerriere, M. Vercelletto, F. De la Fourniere, and C. Thomas-Anterion Phenotype associated with APP duplication in five families Brain 129 2006 2966 2976
11. D. Campion, A. Brice, D. Hannequin, S. Tardieu, B. Dubois, and A. Calenda A large pedigree with early-onset Alzheimer's disease: clinical, neuropathologic, and genetic characterization Neurology 45 1995 80 85
12. D. Campion, C. Dumanchin, D. Hannequin, B. Dubois, S. Belliard, and M. Puel Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum Am J Hum Genet 65 1999 664 670
13. A.M. Cataldo, S. Petanceska, N.B. Terio, C.M. Peterhoff, R. Durham, and M. Mercken Abeta localization in abnormal endosomes: association with earliest Abeta elevations in AD and Down syndrome Neurobiol Aging 25 2004 1263 1272
14. R. Crook, A. Verkkoniemi, J. Perez-Tur, N. Mehta, M. Baker, and H. Houlden A variant of Alzheimer's disease with spastic paraparesis and unusual plaques due to deletion of exon 9 of presenilin 1 Nat Med 4 1998 452 455
15. K.N. Dahlgren, A.M. Manelli, W.B. Stine Jr., L.K. Baker, G.A. Krafft, and M.J. LaDu Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability J Biol Chem 277 2002 32046 32053
16. B. De Strooper Loss-of-function presenilin mutations in Alzheimer disease EMBO Rep 8 2007 141 146
17. B. Dermaut, S. Kumar-Singh, C. De Jonghe, M. Cruts, A. Lofgren, and U. Lubke Cerebral amyloid angiopathy is a pathogenic lesion in Alzheimer's disease due to a novel presenilin 1 mutation Brain 124 2001 2383 2392
18. B. Dermaut, S. Kumar-Singh, S. Engelborghs, J. Theuns, R. Rademakers, and J. Saerens A novel presenilin 1 mutation associated with Pick's disease but not beta-amyloid plaques Ann Neurol 55 2004 617 626
19. J.E. Donahue, J.S. Khurana, and L.S. Adelman Intracerebral hemorrhage in two patients with Down's syndrome and cerebral amyloid angiopathy Acta Neuropathol (Berl) 95 1998 213 216
20. C. Dumanchin, I. Tournier, C. Martin, M. Didic, S. Belliard, and B. Carlander Biological effects of four PSEN1 gene mutations causing Alzheimer disease with spastic paraparesis and cotton wool plaques Hum Mutat 27 2006 1063
21. C. Duyckaerts Nosology of dementias: the neuropathologist's point of view Rev Neurol (Paris) 162 2006 921 928
22. U. Finckh, A. Alberici, M. Antoniazzi, L. Benussi, V. Fedi, and C. Giannini Variable expression of familial Alzheimer disease associated with presenilin 2 mutation M239I Neurology 54 2000 2006 2008
23. A. Goate, M.C. Chartier-Harlin, M. Mullan, J. Brown, F. Crawford, and L. Fidani Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease Nature 349 1991 704 706 (Pubitemid 21912142)
24. A.K. Godbolt, J.A. Beck, J. Collinge, P. Garrard, J.D. Warren, and N.C. Fox A presenilin 1 R278I mutation presenting with language impairment Neurology 63 2004 1702 1704
25. A.K. Godbolt, A.D. Waldman, D.G. MacManus, J.M. Schott, C. Frost, and L. Cipolotti MRS shows abnormalities before symptoms in familial Alzheimer disease Neurology 66 2006 718 722
26. L. Guyant-Marechal, E. Berger, A. Laquerriere, A. Rovelet-Lecrux, G. Viennet, and T. Frebourg Intrafamilial diversity of phenotype associated with APP duplication Neurology 2008
27. K.A. Gyure, R. Durham, W.F. Stewart, J.E. Smialek, and J.C. Troncoso Intraneuronal abeta-amyloid precedes development of amyloid plaques in Down syndrome Arch Pathol Lab Med 125 2001 489 492
28. G. Halliday, W. Brooks, H. Arthur, H. Creasey, and G.A. Broe Further evidence for an association between a mutation in the APP gene and Lewy body formation Neurosci Lett 227 1997 49 52
29. G.M. Halliday, Y.J. Song, G. Lepar, W.S. Brooks, J.B. Kwok, and C. Kersaitis Pick bodies in a family with presenilin-1 Alzheimer's disease Ann Neurol 57 2005 139 143
30. D. Hannequin, and D. Campion Les formes autosomiques dominantes de la maladie d'Alzheimer: du genotype au phénotype Rev Neurol (Paris) 157 2001 384 392
31. S. Hattori, K. Sakuma, Y. Wakutani, K. Wada, M. Shimoda, and K. Urakami A novel presenilin 1 mutation (Y154N) in a patient with early onset Alzheimer's disease with spastic paraparesis Neurosci Lett 368 2004 319 322
32. M. Hiltunen, S. Helisalmi, A. Mannermaa, I. Alafuzoff, A.M. Koivisto, and M. Lehtovirta Identification of a novel 4.6-kb genomic deletion in presenilin-1 gene which results in exclusion of exon 9 in a Finnish early onset Alzheimer's disease family: an Alu core sequence-stimulated recombination? Eur J Hum Genet 8 2000 259 266
33. H. Houlden, M. Baker, E. McGowan, P. Lewis, M. Hutton, and R. Crook Variant Alzheimer's disease with spastic paraparesis and cotton wool plaques is caused by PS-1 mutations that lead to exceptionally high amyloid-beta concentrations Ann Neurol 48 2000 806 808
34. S. Iglesias, F. Chapon, and J.C. Baron Familial occipital calcifications, hemorrhagic strokes, leukoencephalopathy, dementia, and external carotid dysplasia Neurology 55 2000 1661 1667
35. T. Iwatsubo, A. Odaka, N. Suzuki, H. Mizusawa, N. Nukina, and Y. Ihara Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43) Neuron 13 1994 45 53
36. J.T. Jarrett, and P.T. Lansburry Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? Cell 73 1993 1055 1058
37. A. Jimenez-Escrig, A. Rabano, C. Guerrero, J. Simon, M.S. Barquero, and I. Guell New V272A presenilin 1 mutation with very early onset subcortical dementia and parkinsonism Eur J Neurol 11 2004 663 669
38. W.E. Klunk, H. Engler, A. Nordberg, Y. Wang, G. Blomqvist, and D.P. Holt Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B Ann Neurol 55 2004 306 319 (Pubitemid 38269583)
39. W.E. Klunk, J.C. Price, C.A. Mathis, N.D. Tsopelas, B.J. Lopresti, and S.K. Ziolko Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees J Neurosci 27 2007 6174 6184
40. S. Kumar-Singh, J. Theuns, B. Van Broeck, D. Pirici, K. Vennekens, and E. Corsmit Mean age-of-onset of familial alzheimer disease caused by presenilin mutations correlates with both increased Abeta42 and decreased Abeta40 Hum Mutat 27 2006 686 695
41. J.B. Kwok, K. Taddei, M. Hallupp, C. Fisher, W.S. Brooks, and G.A. Broe Two novel (M233T and R278T) presenilin-1 mutations in early-onset Alzheimer's disease pedigrees and preliminary evidence for association of presenilin-1 mutations with a novel phenotype Neuroreport 8 1997 1537 1542
42. F. Lai, and R.S. Williams A prospective study of Alzheimer disease in Down syndrome Arch Neurol 46 1989 849 853
43. M.T. Lai, E. Chen, M.C. Crouthamel, J. DiMuzio-Mower, M. Xu, and Q. Huang Presenilin-1 and presenilin-2 exhibit distinct yet overlapping gamma-secretase activities J Biol Chem 278 2003 22475 22481
44. D. Langui, N. Girardot, K.H. El Hachimi, B. Allinquant, V. Blanchard, and L. Pradier Subcellular topography of neuronal Abeta peptide in APPxPS1 transgenic mice Am J Pathol 165 2004 1465 1477
45. P.L. Lantos, I.M. Ovenstone, J. Johnson, C.A. Clelland, P. Roques, and M.N. Rossor Lewy bodies in the brain of two members of a family with the 717 (Val to Ile) mutation of the amyloid precursor protein gene Neurosci Lett 172 1994 77 79
46. A.J. Larner The cerebellum in Alzheimer's disease Dement Geriatr Cogn Disord 8 1997 203 209
47. A.J. Larner, and M. Doran Clinical phenotypic heterogeneity of Alzheimer's disease associated with mutations of the presenilin-1 gene J Neurol 253 2006 139 158
48. A.J. Larner, P.S. Ray, and M. Doran The R269H mutation in presenilin-1 presenting as late-onset autosomal dominant Alzheimer's disease J Neurol Sci 252 2007 173 176
49. J.B. Leverenz, M.A. Fishel, E.R. Peskind, T.J. Montine, D. Nochlin, and E. Steinbart Lewy body pathology in familial Alzheimer disease: evidence for disease- and mutation-specific pathologic phenotype Arch Neurol 63 2006 370 376
50. E. Levy-Lahad, W. Wasco, P. Poorkaj, D.M. Romano, J. Oshima, and W.H. Pettingell Candidate gene for the chromosome 1 familial Alzheimer's disease locus Science 269 1995 973 977
51. P.A. Lewis, J. Perez-Tur, T.E. Golde, and J. Hardy The presenilin 1 C92S mutation increases abeta 42 production Biochem Biophys Res Commun 277 2000 261 263
52. C.F. Lippa, H. Fujiwara, D.M. Mann, B. Giasson, M. Baba, and M.L. Schmidt Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes Am J Pathol 153 1998 1365 1370
53. C.F. Lippa, M.L. Schmidt, V.M. Lee, and J.Q. Trojanowski Antibodies to alpha-synuclein detect Lewy bodies in many Down's syndrome brains with Alzheimer's disease Ann Neurol 45 1999 353 357
54. M. Maat-Schieman, R. Roos, and S. van Duinen Hereditary cerebral hemorrhage with amyloidosis-Dutch type Neuropathology 25 2005 288 297
55. D.M. Mann, S.M. Pickering-Brown, A. Takeuchi, and T. Iwatsubo Amyloid angiopathy and variability in amyloid beta deposition is determined by mutation position in presenilin-1-linked Alzheimer's disease Am J Pathol 158 2001 2165 2175
56. M.G. Marrosu, G. Floris, G. Costa, L. Schirru, G. Spinicci, and M.V. Cherchi Dementia, pyramidal system involvement, and leukoencephalopathy with a presenilin 1 mutation Neurology 66 2006 108 111
57. J.J. Martin, J. Gheuens, M. Bruyland, P. Cras, A. Vandenberghe, and C.L. Masters Early-onset Alzheimer's disease in 2 large Belgian families Neurology 41 1991 62 68
58. E. Masliah, E. Rockenstein, I. Veinbergs, Y. Sagara, M. Mallory, and M. Hashimoto beta-amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease Proc Natl Acad Sci USA 98 2001 12245 12250
59. E. McGowan, F. Pickford, J. Kim, L. Onstead, J. Eriksen, and C. Yu Abeta42 is essential for parenchymal and vascular amyloid deposition in mice Neuron 47 2005 191 199
60. J. Miklossy, K. Taddei, D. Suva, G. Verdile, J. Fonte, and C. Fisher Two novel presenilin-1 mutations (Y256S and Q222H) are associated with early-onset Alzheimer's disease Neurobiol Aging 24 2003 655 662
61. L. Miravalle, M. Calero, M. Takao, A.E. Roher, B. Ghetti, and R. Vidal Amino-terminally truncated Abeta peptide species are the main component of cotton wool plaques Biochemistry 44 2005 10810 10821
62. T. Moehlmann, E. Winkler, X. Xia, D. Edbauer, J. Murrell, and A. Capell Presenilin-1 mutations of leucine 166 equally affect the generation of the Notch and APP intracellular domains independent of their effect on Abeta 42 production Proc Natl Acad Sci USA 99 2002 8025 8030
63. P. Moretti, A.P. Lieberman, E.A. Wilde, B.I. Giordani, K.J. Kluin, and R.A. Koeppe Novel insertional presenilin 1 mutation causing Alzheimer disease with spastic paraparesis Neurology 62 2004 1865 1868
64. C. Mori, E.T. Spooner, K.E. Wisniewsk, T.M. Wisniewski, H. Yamaguch, and T.C. Saido Intraneuronal Abeta42 accumulation in Down syndrome brain Amyloid 9 2002 88 102
65. D. Neary, J.S. Snowden, L. Gustafson, U. Passant, D. Stuss, and S. Black Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria Neurology 51 1998 1546 1554
66. S. O'Riordan, P. McMonagle, J.C. Janssen, N.C. Fox, M. Farrell, and J. Collinge Presenilin-1 mutation (E280G), spastic paraparesis, and cranial MRI white-matter abnormalities Neurology 59 2002 1108 1110
67. P. Pastor, C.M. Roe, A. Villegas, G. Bedoya, S. Chakraverty, and G. Garcia Apolipoprotein Eepsilon4 modifies Alzheimer's disease onset in an E280A PS1 kindred Ann Neurol 54 2003 163 169
68. J. Perez-Tur, S. Froelich, G. Prihar, R. Crook, M. Baker, and K. Duff A mutation in Alzheimer's disease destroying a splice acceptor site in the presenilin-1 gene Neuroreport 7 1995 297 301
69. A. Piccini, G. Zanusso, R. Borghi, C. Noviello, S. Monaco, and R. Russo Association of a presenilin 1 S170F mutation with a novel Alzheimer disease molecular phenotype Arch Neurol 64 2007 738 745
70. P. Piscopo, G. Marcon, M.R. Piras, A. Crestini, L.M. Campeggi, and E. Deiana A novel PSEN2 mutation associated with a peculiar phenotype Neurology 70 2008 1549 1554
71. G. Prihar, A. Verkkoniem, J. Perez-Tur, R. Crook, S. Lincoln, and H. Houlden Alzheimer disease PS-1 exon 9 deletion defined Nat Med 5 1999 1090
72. G. Raux, R. Gantier, C. Thomas-Anterion, J. Boulliat, P. Verpillat, and D. Hannequin Dementia with prominent frontotemporal features associated with L113P presenilin 1 mutation Neurology 55 2000 1577 1578
73. G. Raux, L. Guyant-Marechal, C. Martin, J. Bou, C. Penet, and A. Brice Molecular diagnosis of autosomal dominant early onset Alzheimer's disease: an update J Med Genet 42 2005 793 795
74. T. Revesz, J.L. McLaughlin, M.N. Rossor, and P.L. Lantos Pathology of familial Alzheimer's disease with Lewy bodies J Neural Transm Suppl 51 1997 121 135
75. B.H. Ridha, J. Barnes, J.W. Bartlett, A. Godbolt, T. Pepple, and M.N. Rossor Tracking atrophy progression in familial Alzheimer's disease: a serial MRI study Lancet Neurol 5 2006 828 834
76. E.A. Rogaeva, K.C. Fafel, Y.Q. Song, H. Medeiros, C. Sato, and Y. Liang Screening for PS1 mutations in a referral-based series of AD cases: 21 novel mutations Neurology 57 2001 621 625
77. G. Roks, F. Van Harskamp, I. De Koning, M. Cruts, C. De Jonghe, and S. Kumar-Singh Presentation of amyloidosis in carriers of the codon 692 mutation in the amyloid precursor protein gene (APP692) Brain 123 2000 2130 2140
78. C.K. Rosenberg, M.A. Pericak-Vance, A.M. Saunders, J.R. Gilbert, P.C. Gaskell, and C.M. Hulette Lewy body and Alzheimer pathology in a family with the amyloid-beta precursor protein APP717 gene mutation Acta Neuropathol 100 2000 145 152
79. A. Rovelet-Lecrux, T. Frebourg, H. Tuominen, K. Majamaa, D. Campion, and A.M. Remes APP locus duplication in a Finnish family with dementia and intracerebral haemorrhage J Neurol Neurosurg Psychiatry 78 2007 1158 1159
80. A. Rovelet-Lecrux, D. Hannequin, G. Raux, N.L. Meur, A. Laquerriere, and A. Vital APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy Nat Genet 38 2006 24 26
81. C.A. Saura, S.Y. Choi, V. Beglopoulos, S. Malkani, D. Zhang, and B.S. Shankaranarayana Rao Loss of presenilin function causes impairments of memory and synaptic plasticity followed by age-dependent neurodegeneration Neuron 42 2004 23 36
82. N. Scarmeas, G.M. Hadjigeorgiou, A. Papadimitriou, B. Dubois, M. Sarazin, and J. Brandt Motor signs during the course of Alzheimer disease Neurology 63 2004 975 982
83. N. Schupf, D. Pang, B.N. Patel, W. Silverman, R. Schubert, and F. Lai Onset of dementia is associated with age at menopause in women with Down's syndrome Ann Neurol 54 2003 433 438
84. G.M. Shankar, B.L. Bloodgood, M. Townsend, D.M. Walsh, D.J. Selkoe, and B.L. Sabatini Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway J Neurosci 27 2007 2866 2875
85. R. Sherrington, S. Froelich, S. Sorbi, D. Campion, H. Chi, and E.A. Rogaeva Alzheimer's disease associated with mutations in presenilin 2 is rare and variably penetrant Hum Mol Genet 5 1996 985 988 (Pubitemid 26232280)
86. R. Sherrington, E.I. Rogaev, Y. Liang, E.A. Rogaeva, G. Levesque, and M. Ikeda Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease Nature 375 1995 754 760
87. K. Sleegers, N. Brouwers, I. Gijselinck, J. Theuns, D. Goossens, and J. Wauters APP duplication is sufficient to cause early onset Alzheimer's dementia with cerebral amyloid angiopathy Brain 129 2006 2977 2983
88. M.J. Smith, J.B. Kwok, C.A. McLean, J.J. Kril, G.A. Broe, and G.A. Nicholson Variable phenotype of Alzheimer's disease with spastic paraparesis Ann Neurol 49 2001 125 129
89. N. Sodeyama, T. Iwata, K. Ishikawa, H. Mizusawa, M. Yamada, and Y. Itoh Very early onset Alzheimer's disease with spastic paraparesis associated with a novel presenilin 1 mutation (Phe237Ile) J Neurol Neurosurg Psychiatry 71 2001 556 557
90. W. Song, P. Nadeau, M. Yuan, X. Yang, J. Shen, and B.A. Yankner Proteolytic release and nuclear translocation of Notch-1 are induced by presenilin-1 and impaired by pathogenic presenilin-1 mutations Proc Natl Acad Sci USA 96 1999 6959 6963
91. S. Sorbi, B. Nacmias, P. Forleo, S. Piacentini, S. Latorraca, and L. Amaducci Epistatic effect of APP717 mutation and apolipoprotein E genotype in familial Alzheimer's disease Ann Neurol 38 1995 124 127
92. T. Tabira, H. Chui de, H. Nakayama, S. Kuroda, and M. Shibuya Alzheimer's disease with spastic paresis and cotton wool type plaques J Neurosci Res 70 2002 367 372
93. R.H. Takahashi, T.A. Milner, F. Li, E.E. Nam, M.A. Edgar, and H. Yamaguchi Intraneuronal Alzheimer abeta42 accumulates in multivesicular bodies and is associated with synaptic pathology Am J Pathol 161 2002 1869 1879
94. D. Tang-Wai, P. Lewis, B. Boeve, M. Hutton, T. Golde, and M. Baker Familial frontotemporal dementia associated with a novel presenilin-1 mutation Dement Geriatr Cogn Disord 14 2002 13 21
95. T. Tomiyama, T. Nagata, H. Shimada, R. Teraoka, A. Fukushima, and H. Kanemitsu A new amyloid beta variant favoring oligomerization in Alzheimer's-type dementia Ann Neurol 63 2008 377 387
96. M. Townsend, G.M. Shankar, T. Mehta, D.M. Walsh, and D.J. Selkoe Effects of secreted oligomers of amyloid beta-protein on hippocampal synaptic plasticity: a potent role for trimers J Physiol 572 2006 477 492
97. A. Verkkoniemi, M. Somer, J.O. Rinne, L. Myllykangas, R. Crook, and J. Hardy Variant Alzheimer's disease with spastic paraparesis: clinical characterization Neurology 54 2000 1103 1109
98. F.E. Visser, A.P. Aldenkamp, A.C. van Huffelen, M. Kuilman, J. Overweg, and J. van Wijk Prospective study of the prevalence of Alzheimer-type dementia in institutionalized individuals with Down syndrome Am J Ment Retard 101 1997 400 412
99. T. Wisniewski, W.K. Dowjat, J.D. Buxbaum, O. Khorkova, S. Efthimiopoulos, and J. Kulczycki A novel Polish presenilin-1 mutation (P117L) is associated with familial Alzheimer's disease and leads to death as early as the age of 28 years Neuroreport 9 1998 217 221
100. M.S. Wolfe When loss is gain: reduced presenilin proteolytic function leads to increased Abeta42/Abeta40. Talking Point on the role of presenilin mutations in Alzheimer disease EMBO Rep 8 2007 136 140
101. C. Zekanowski, M.P. Golan, K.A. Krzysko, W. Lipczynska-Lojkowska, S. Filipek, and A. Kowalska Two novel presenilin 1 gene mutations connected with frontotemporal dementia-like clinical phenotype: genetic and bioinformatic assessment Exp Neurol 200 2006 82 88